-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Xylem, Lowers Price Target to $166

Benzinga·01/07/2026 18:52:36
語音播報
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $172 to $166.